top
Please input keywords
Order
*Country
United States
China
France
Germany
Netherlands
United Kingdom
Japan
South Korea
Israel
Australia
Hong Kong, China
New Zealand
Russia
Singapore
Taiwan, China
India
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua & Barbuda
Argentina
Armenia
Aruba
Ascension Island
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia & Herzegovina
Botswana
Brazil
British Indian Ocean Territory
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Canary Islands
Cape Verde
Caribbean Netherlands
Cayman Islands
Central African Republic
Ceuta & Melilla
Chad
Chile
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo - Brazzaville
Congo - Kinshasa
Cook Islands
Costa Rica
Côte d’Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czechia
Denmark
Diego Garcia
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
Hungary
Iceland
Indonesia
Iran
Iraq
Ireland
Isle of Man
Italy
Jamaica
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kosovo
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau, China
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar (Burma)
Namibia
Nauru
Nepal
New Caledonia
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territories
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Islands
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Rwanda
Samoa
San Marino
São Tomé & Príncipe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Sint Maarten
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia & South Sandwich Islands
South Sudan
Spain
Sri Lanka
St. Barthélemy
St. Helena
St. Kitts & Nevis
St. Lucia
St. Martin
St. Pierre & Miquelon
St. Vincent & Grenadines
Sudan
Suriname
Svalbard & Jan Mayen
Swaziland
Sweden
Switzerland
Syria
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad & Tobago
Tristan da Cunha
Tunisia
Turkey
Turkmenistan
Turks & Caicos Islands
Tuvalu
U.S. Outlying Islands
U.S. Virgin Islands
Uganda
Ukraine
United Arab Emirates
United Nations
Uruguay
Uzbekistan
Vanuatu
Vatican City
Venezuela
Vietnam
Wallis & Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
*Province
*City
*Name
*Telephone
*Company
*Position
*Email
*Verification code
*Verification Code
B-NDG hCSF1/hTHPO mice

Strain Name 

NOD.CB17-Prkdcscid Il2rgtm1Bcgen 

Csf1tm1(CSF1)Bcgen Thpotm1(THPO)Bcgen/Bcgen

Common Name 

B-NDG hCSF1/hTHPO  mice

Background B-NDG Catalog number  120609
Related Genes 

CSF1 (MCSF),THPO  (thrombopoietin)

NCBI Gene ID
12977,21832


Protein expression analysis


from clipboard


Strain specific CSF1 and THPO expression analysis in B-NDG mice and homozygous B-NDG hCSF1/hTHPO mice by ELISA. Serum were collected from B-NDG  mice and homozygous B-NDG hCSF1/hTHPO mice stimulated with LPS in vivo, and analyzed by ELISA with species-specific CSF1 and THPO antibodies. Mouse CSF1 and THPO were only detectable in B-NDG mice (A, C). Human CSF1 and THPO were exclusively detectable in homozygous B-NDG hCSF1/hTHPO mice but not in B-NDG mice (B, D).

Engraftment of human CD34+ HSCs in B-NDG hCSF1/hTHPO mice to reconstitute human immune system (adult mice)

from clipboard


Human CD34+ HSCs (hematopoietic stem cells) (1.5×105) were intravenously injected into homozygote B-NDG hCSF1/hTHPO mice (female, 6 week-old, n=15). Representative flow cytometric analysis of peripheral blood lymphocyte from mice after engraftment with human CD34+ HSCs. Human multi-lineage cells, including T, B, NK, myeloid cells, monocytes and neutrophils were successfully reconstituted. Our results suggest that the human HSCs engrafted humanized mouse model was successfully constructed.

Engraftment of human CD34+ HSCs in B-NDG hCSF1/hTHPO mice to reconstitute human immune system (neonatal mice)

from clipboard


Human CD34+ HSCs (3×104) were intravenous (temporal vein) engrafted into homozygous B-NDG hCSF1/hTHPO mice (female, 24-48 hr after birth, n=11). A. Survival rates of the mice were analyzed with Kaplan Meier survival curves. B. Body weight. Results showed that the survival rate of B-NDG hCSF1/hTHPO mice was 100% after engraftment of human CD34+ HSCs for 16 weeks. The body weight of B-NDG hCSF1/hTHPO  mice was increased steadily during the whole reconstitution. Values are expressed as mean ± SEM. HSCs: hematopoietic stem cells.

from clipboard


Human CD34+ HSCs (3×104) were intravenous (temporal vein) engrafted into homozygous B-NDG hCSF1/hTHPO mice (female, 24-48 hr after birth, n=11). The frequency of human immune cells in peripheral blood was analyzed by flow cytometry. Results showed that multi-lineage of human cells, including T, B, NK, myeloid cells, monocytes, granulocytes, cDCs, pDCs, Tregs were reconstituted. Values are expressed as mean ± SEM. 

from clipboard


Human CD34+ HSCs (3×104) were intravenous (temporal vein) engrafted into homozygous B-NDG hCSF1/hTHPO mice (female, 24-48 hr after birth, n=11). The absolute number of human immune cells in peripheral blood was analyzed by flow cytometry. Results showed that multi-lineage of human cells, including T, B, NK, myeloid cells, monocytes, granulocytes, cDCs, pDCs, Tregs were reconstituted. Values are expressed as mean ± SEM.